Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

5.2K
Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
5.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hemopexin Purification From Human Cohn Fraction IV Paste and Its Biophysical Characterization and Functional Evaluation in Sickle Cell Disease Mice.

Biotechnology and bioengineering·2026
Same author

The resurgence of whole blood transfusion: Evaluating microcirculatory evidence in hemorrhagic trauma care: A review.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis·2026
Same author

Sex determines cardiac and renal Vulnerability to chronic hemoglobin toxicity.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie·2026
Same author

Intermittent Hypoxia Associated with Sleep Apnea Disrupts Microvascular Hemodynamics and Oxygen Delivery.

Communications biology·2026
Same author

Acellular Hemoglobin Impairs Cardiomyocyte Excitation-Contraction Coupling.

ASAIO journal (American Society for Artificial Internal Organs : 1992)·2026
Same author

Modulatory effects of exogenous estradiol during endotoxemia.

The international journal of biochemistry & cell biology·2026

Related Experiment Video

Updated: Mar 22, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.4K

Rockets, radiosensitizers, and RRx-001: an origin story part I.

Bryan Oronsky1, Jan Scicinski1, Shoucheng Ning2

  • 1EpicentRx Inc., 800 W. El Camino Real, Suite 180, Mountain View, CA 94040, USA.

Discovery Medicine
|April 27, 2016
PubMed
Summary

This review details the origin of RRx-001, an anticancer agent repurposed from aerospace technology. It highlights energetic chemistry

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K
Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites
05:28

Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites

Published on: June 2, 2023

1.5K

Related Experiment Videos

Last Updated: Mar 22, 2026

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes
08:32

Genome-Wide CRISPR Screen for Unveiling Radiosensitive and Radioresistant Genes

Published on: May 23, 2025

1.4K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.4K
Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites
05:28

Monitoring On-Target Signaling Responses in Larval Zebrafish - Z-REX Unmasks Precise Mechanisms of Electrophilic Drugs and Metabolites

Published on: June 2, 2023

1.5K

Area of Science:

  • Oncology
  • Aerospace Medicine
  • Medicinal Chemistry

Background:

  • Anticancer drug development often involves repurposing compounds from diverse fields.
  • Energetic chemistry has a historical precedent in therapeutic applications, such as nitroglycerin and hydralazine.
  • RRx-001 represents a novel application of energetic chemistry in oncology.

Purpose of the Study:

  • To present the origin and development of RRx-001 as a radiosensitizer.
  • To explore the unique journey of RRx-001 from aerospace to oncology.
  • To establish the foundation for future reviews on RRx-001's broader therapeutic applications.

Main Methods:

  • Literature review of RRx-001's developmental history.
  • Analysis of historical precedents in repurposing energetic compounds for medical use.
  • Focus on RRx-001's initial development as a radiosensitizer.

Main Results:

  • RRx-001 originated from the aerospace industry.
  • The compound was initially investigated as a radiosensitizer.
  • This review focuses on the radiosensitization aspect (Part 1).

Conclusions:

  • RRx-001's development showcases a unique interdisciplinary origin.
  • The compound's potential as a radiosensitizer is a key aspect of its therapeutic narrative.
  • Future research will explore RRx-001's efficacy in other cancer types and diseases.